RUBIUS THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for RUBIUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RUBIUS THERAPEUTICS trademark a serial number of 87287699. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Rubius Therapeutics, Inc.. The RUBIUS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders

scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
rubius therapeutics

General Information

Serial Number87287699
Word MarkRUBIUS THERAPEUTICS
Filing DateTuesday, January 3, 2017
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6158400
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 3, 2018

Trademark Statements

Goods and Servicescells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesscientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2017
Primary Code005
First Use Anywhere DateTuesday, October 15, 2019
First Use In Commerce DateTuesday, October 15, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2017
Primary Code042
First Use Anywhere DateWednesday, December 9, 2015
First Use In Commerce DateWednesday, December 9, 2015

Trademark Owner History

Party NameRubius Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRubius Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRubius Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 28, 2017ASSIGNED TO EXAMINER
Tuesday, April 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2017NON-FINAL ACTION WRITTEN
Tuesday, September 26, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 4, 2017ASSIGNED TO LIE
Saturday, October 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 4, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, November 4, 2017FINAL REFUSAL E-MAILED
Saturday, November 4, 2017FINAL REFUSAL WRITTEN
Wednesday, May 2, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 2, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 2, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 3, 2018ACTION CONTINUING A FINAL - COMPLETED
Thursday, May 3, 2018NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Thursday, May 3, 2018CONTINUATION OF FINAL REFUSAL E-MAILED
Tuesday, May 29, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 29, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, May 29, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 29, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, May 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 13, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 3, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 28, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 6, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 6, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 25, 2019SOU TEAS EXTENSION RECEIVED
Monday, February 25, 2019SOU EXTENSION 1 FILED
Monday, February 25, 2019SOU EXTENSION 1 GRANTED
Wednesday, February 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2019SOU TEAS EXTENSION RECEIVED
Friday, August 23, 2019SOU EXTENSION 2 FILED
Tuesday, August 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 27, 2019SOU EXTENSION 2 GRANTED
Wednesday, August 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 26, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, February 26, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 26, 2020SOU EXTENSION 3 FILED
Wednesday, February 26, 2020USE AMENDMENT FILED
Tuesday, March 10, 2020SOU EXTENSION 3 GRANTED
Tuesday, March 10, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 10, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 10, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 18, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 19, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics rubius diseases disorders research medical development namely scientific genitourinary deficiency gastrointestinal